Suppr超能文献

心脏磁共振成像对肥厚型心肌病诊断的影响——10 年 1000 多例患者的经验。

Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.

机构信息

Magnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.

Department of Cardiology and Interventional Angiology, National Institute of Cardiology, Warsaw, Poland.

出版信息

Eur Radiol. 2021 Mar;31(3):1194-1205. doi: 10.1007/s00330-020-07207-8. Epub 2020 Sep 2.

Abstract

OBJECTIVES

To assess the value of cardiac MRI in comparison to echocardiography in consecutive patients with previously diagnosed and new suspected hypertrophic cardiomyopathy (HCM).

METHODS

All MRI studies of patients with HCM or suspected disease performed at our centre within a 10-year time period were evaluated. Initial diagnoses (echocardiography-based) and final (MRI-based) diagnoses were compared in subgroups, and the discrepancies were recorded.

RESULTS

A total of 1006 subjects with HCM or suspected HCM were identified (61% males, 39% females; median age, 49.1 years; interquartile range, 34.9-60.4). In 12 (2.2%) out of 550 patients with known HCM, MRI indicated a diagnosis other than HCM, including but not limited to the subaortic membrane (n = 1, 8.3%) or mild left ventricular hypertrophy (n = 5, 41.7%). Among all patients with suspected HCM (n = 456), MRI diagnosis was different from HCM in 5.3% (n = 24) of patients. In an additional 20.4% of patients (n = 93), no significant hypertrophy was present. In total, among patients with suspected HCM, MRI led to clear HCM diagnosis in 204 (44.7%) patients. Among patients with a history of uncontrolled hypertension suspected of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis, namely, 29.6% compared with 13.8% in the remaining groups of patients with suspected HCM (p = 0.0001).

CONCLUSIONS

In a small but important group of patients with ultrasound-based HCM, cardiac MRI can diagnose previously unknown conditions and/or refute suspected cardiomyopathy. The diagnostic yield of MRI when compared to echocardiography in patients suspected of having HCM is 44.7%.

KEY POINTS

• Out of 550 patients previously diagnosed with echocardiography but without magnetic resonance imaging (MRI) as having hypertrophic cardiomyopathy (HCM), we diagnosed a different disease in 12 (2.2%) patients using MRI. • Among patients with suspected HCM based on echocardiography, MRI led to clear HCM diagnosis in 44.7% of patients. • In patients with a history of uncontrolled hypertension suspected, based on an echocardiogram, of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis.

摘要

目的

评估心脏 MRI 在连续诊断为先前诊断和新疑似肥厚型心肌病(HCM)的患者中的价值。

方法

评估了在 10 年内我们中心进行的所有 HCM 或疑似疾病患者的 MRI 研究。比较了亚组中的初始诊断(基于超声心动图)和最终诊断(基于 MRI),并记录了差异。

结果

共确定了 1006 名 HCM 或疑似 HCM 患者(61%为男性,39%为女性;中位年龄 49.1 岁;四分位间距 34.9-60.4)。在已知 HCM 的 550 名患者中,有 12 名(2.2%)MRI 显示的诊断不是 HCM,包括但不限于主动脉瓣下膜(n=1,8.3%)或轻度左心室肥厚(n=5,41.7%)。在所有疑似 HCM 的患者中(n=456),MRI 诊断在 5.3%(n=24)患者中与 HCM 不同。在另外 20.4%(n=93)的患者中,没有明显的肥大。总的来说,在疑似 HCM 的患者中,MRI 明确诊断为 HCM 的患者为 204 名(44.7%)。在既往有未控制高血压病史且疑似患有 HCM 的患者中,MRI 有助于识别心肌病的患者占 47.9%。该亚组包含最多比例的诊断不明确的患者,即 29.6%,而疑似 HCM 的其余患者组中这一比例为 13.8%(p=0.0001)。

结论

在一小部分超声心动图诊断为 HCM 的患者中,心脏 MRI 可以诊断出先前未知的疾病和/或排除疑似的心肌病。与超声心动图相比,MRI 在疑似患有 HCM 的患者中的诊断率为 44.7%。

关键点

  • 在先前通过超声心动图诊断为患有肥厚型心肌病(HCM)但没有进行磁共振成像(MRI)检查的 550 名患者中,我们通过 MRI 诊断出 12 名(2.2%)患者患有其他疾病。

  • 在基于超声心动图疑似患有 HCM 的患者中,MRI 明确诊断为 HCM 的患者占 44.7%。

  • 在既往有未控制高血压病史且疑似患有 HCM 的患者中,基于超声心动图,MRI 有助于识别心肌病的患者占 47.9%。该亚组包含最多比例的诊断不明确的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/7880911/1f844ba95949/330_2020_7207_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验